Effects of oral and transdermal low-dose estrogen therapy on echocardiographic parameters of cardiac function Tatjana E Vogelvang, M.D., Marius J van der Mooren, Ph.D., Otto Kamp, Ph.D., Velja Mijatovic, Ph.D., Cees A Visser, Ph.D., Peter Kenemans, Ph.D. Fertility and Sterility Volume 80, Issue 3, Pages 546-553 (September 2003) DOI: 10.1016/S0015-0282(03)00754-4
FIGURE 1 Trial profile of the study. n = number of participants; tE2 = transdermal 17β-estradiol, 50 μg; oE2 = oral micronized 17β-estradiol, 1 mg; oE2+G = oE2 plus gestodene, 25 μg; numbers in parentheses represent numbers of participants included in the study for whom no echocardiography was performed. Vogelvang. Estrogen therapy and echocardiography. Fertil Steril 2003. Fertility and Sterility 2003 80, 546-553DOI: (10.1016/S0015-0282(03)00754-4)